New EV sources and delivery methods may help treat atopic dermatitis

Atopic dermatitis causes itchy, inflamed skin that disrupts daily life. A recent narrative review looks at extracellular vesicles as a potential new treatment option. These are tiny particles that cells release to send signals to other cells. Scientists are testing vesicles from many different sources. These include bacteria like Staphylococcus aureus, fungi like Malassezia, host mast cells, mesenchymal stem cells, plants, probiotics, and marine organisms. Researchers are also testing strategies like preconditioning, genetic engineering, hybrid vesicles, and advanced delivery systems to make them work better. The goal is to find a safe and effective way to calm the skin. This review highlights the wide variety of materials being investigated. It shows that scientists are thinking creatively about how to deliver these treatments. However, the current information comes from uneven source selection and a lack of standardization in how these vesicles are prepared and characterized. There is also insufficient understanding of exactly how they work inside the body. Preclinical models used in labs have their own limitations. We do not yet have enough data on how long these treatments stay in the body or their long-term safety. Because of these gaps, we cannot say for sure if this approach will work for patients yet. More work is needed to prove safety and effectiveness before doctors can recommend this widely.